Trial Profile
Phase Ib trial of TRC-105 in combination with regorafenib [Stivarga] in patients with colorectal cancer
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 07 Aug 2015
Price :
$35
*
At a glance
- Drugs Carotuximab (Primary) ; Regorafenib
- Indications Colorectal cancer
- Focus Adverse reactions
- Sponsors Acerus Pharmaceuticals
- 07 Aug 2015 New trial record
- 05 Aug 2015 According to a TRACON Pharmaceuticals media release, this trial is expected to be initiated before the end of 2015.